IN-DATE
EMR2: AtriCure Isolator Synergy Clamp, Right Curve
Sign in to add this product to your favorites!
| Price: | $10.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 14 eaches |
| Status: | expired |
Additional Details
Isolator Synergy Clamp
EMR2
- Right Curve Dual Electrode Pairs
- 65mm Jaw Length
AtriCure’s Isolator Synergy Ablation System is the only FDA-approved device for the treatment of persistent atrial fibrillation and longstanding persistent atrial fibrillation.
AccessGUDID Info
- FDA Product Code: OCL
- FDA Product Code Name: Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue
- GMDN Term Code: 60784
- GMDN Term Name: Cardiac radio-frequency ablation system generator
- GMDN Term Description: An electrically-powered, noninvasive device intended to be used to generate radio-frequency energy to create ablative lesions in the cardiac tissue of a beating heart in the treatment of cardiac arrhythmias. The generator includes controls and may include electrocardiograph (ECG) interfacing/monitoring functionality. It may be intended to be used with a radio-frequency catheter for endocardial ablation and/or an epicardial probe for epicardial ablation.
More on Ablation | RF
Radiofrequency (RF) Ablation is a widely used thermal ablation technique that destroys targeted tissue by delivering high-frequency alternating current through a catheter or probe. The electrical energy creates heat, leading to localized coagulative necrosis and cell death. In cardiology, RF ablation is a cornerstone treatment for arrhythmias like atrial fibrillation, while in oncology, it’s used to treat tumors in the liver, kidney, lung, and other organs. RF ablation is valued for its precision, proven track record, and ability to be performed in a minimally invasive setting, often under imaging guidance.
Manufacturer
AtriCure is a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions. Electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. The Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. The AtriClip Left Atrial Appendage Exclusion System products are the most widely used LAA management devices worldwide. The Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients, and the cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures.
